NCT02444793 2019-02-27A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid TumorsPfizerPhase 1 Terminated24 enrolled 34 charts
NCT02179918 2019-02-08A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)PfizerPhase 1 Completed23 enrolled 27 charts